Details for New Drug Application (NDA): 022567

✉ Email this page to a colleague

NDA 022567 describes VIIBRYD, which is a drug marketed by Abbvie and is included in one NDA. It is available from three suppliers. Additional details are available on the VIIBRYD profile page.

The generic ingredient in VIIBRYD is vilazodone hydrochloride. There are fourteen drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the vilazodone hydrochloride profile page.

Summary for 022567

Tradename:	VIIBRYD
Applicant:	Abbvie
Ingredient:	vilazodone hydrochloride
Patents:	0

Medical Subject Heading (MeSH) Categories for 022567

Antidepressive Agents
Serotonin 5-HT1 Receptor Agonists
Serotonin Uptake Inhibitors

Suppliers and Packaging for NDA: 022567

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
VIIBRYD	vilazodone hydrochloride	TABLET;ORAL	022567	NDA	Allergan, Inc.	0456-1110	0456-1110-30	30 TABLET in 1 BOTTLE (0456-1110-30)
VIIBRYD	vilazodone hydrochloride	TABLET;ORAL	022567	NDA	Allergan, Inc.	0456-1120	0456-1120-30	30 TABLET in 1 BOTTLE (0456-1120-30)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	10MG
Approval Date:	Jan 21, 2011	TE:	AB	RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	20MG
Approval Date:	Jan 21, 2011	TE:	AB	RLD:	Yes

Profile for product number 003

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	40MG
Approval Date:	Jan 21, 2011	TE:	AB	RLD:	Yes

Expired US Patents for NDA 022567

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Abbvie	VIIBRYD	vilazodone hydrochloride	TABLET;ORAL	022567-001	Jan 21, 2011	5,532,241	⤷ Get Started Free
Abbvie	VIIBRYD	vilazodone hydrochloride	TABLET;ORAL	022567-003	Jan 21, 2011	5,532,241	⤷ Get Started Free
Abbvie	VIIBRYD	vilazodone hydrochloride	TABLET;ORAL	022567-002	Jan 21, 2011	5,532,241	⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.